Emi Noguchi

1.1k total citations
63 papers, 608 citations indexed

About

Emi Noguchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Emi Noguchi has authored 63 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Emi Noguchi's work include Sarcoma Diagnosis and Treatment (14 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer Treatment and Pharmacology (8 papers). Emi Noguchi is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer Treatment and Pharmacology (8 papers). Emi Noguchi collaborates with scholars based in Japan, United States and United Kingdom. Emi Noguchi's co-authors include Kan Yonemori, Tatsunori Shimoi, Yasuhiro Fujiwara, Kenji Tamura, Akihiko Shimomura, Masayuki Yoshida, Mayu Yunokawa, Chikako Shimizu, Kazuki Sudo and Takayuki Kinoshita and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Emi Noguchi

59 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emi Noguchi Japan	12	352	208	120	115	76	63	608
Douglas Adkins United States	8	360 1.0×	389 1.9×	89 0.7×	74 0.6×	48 0.6×	19	659
Kuniko Sunami Japan	16	320 0.9×	297 1.4×	196 1.6×	150 1.3×	42 0.6×	47	638
James Creeden United States	11	183 0.5×	177 0.9×	90 0.8×	80 0.7×	63 0.8×	26	483
Matthew Hiemenz United States	12	179 0.5×	155 0.7×	104 0.9×	75 0.7×	30 0.4×	43	448
Suneel D. Kamath United States	14	435 1.2×	225 1.1×	116 1.0×	180 1.6×	115 1.5×	57	767
Thomas Grellety France	12	399 1.1×	274 1.3×	96 0.8×	113 1.0×	149 2.0×	42	613
Fang Li China	14	268 0.8×	289 1.4×	47 0.4×	126 1.1×	45 0.6×	84	610
Matilde Cacciatore Italy	12	293 0.8×	161 0.8×	166 1.4×	122 1.1×	47 0.6×	21	630
Marina Pulido France	10	315 0.9×	275 1.3×	84 0.7×	73 0.6×	134 1.8×	25	522
Antonio De Leo Italy	17	228 0.6×	230 1.1×	155 1.3×	191 1.7×	59 0.8×	101	869

Countries citing papers authored by Emi Noguchi

Since Specialization

Citations

This map shows the geographic impact of Emi Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Noguchi more than expected).

Fields of papers citing papers by Emi Noguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Noguchi. The network helps show where Emi Noguchi may publish in the future.

Co-authorship network of co-authors of Emi Noguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Noguchi. A scholar is included among the top collaborators of Emi Noguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Noguchi. Emi Noguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kojima, Yuki, Hiroshi Yoshida, Rui Kitadai, et al.. (2024). Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer. International Journal of Gynecological Pathology. 44(2). 104–111. 3 indexed citations

Shimoi, Tatsunori, Yuki Kojima, T. Yamanaka, et al.. (2024). Abstract PO3-15-12: Expression and co-expression patterns of TROP2 and HER2 in breast cancer: implications for bispecific antibody-drug conjugate therapy. Cancer Research. 84(9_Supplement). PO3–15. 2 indexed citations

Kojima, Yuki, Hiroshi Yoshida, Rui Kitadai, et al.. (2024). Trop-2 expression and the tumor immune microenvironment in cervical cancer. Gynecologic Oncology. 187. 51–57. 10 indexed citations

Imai, Toru, Yuki Kojima, Tatsunori Shimoi, et al.. (2024). Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis. Anticancer Research. 44(5). 2125–2132. 1 indexed citations

Kojima, Yuki, Emi Noguchi, Shigehiro Yagishita, et al.. (2023). Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping. Diagnostics. 13(12). 2040–2040. 1 indexed citations

Shimoi, Tatsunori, Ayumi Saito, Yuki Kojima, et al.. (2023). Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(6). 855–863. 5 indexed citations

Kojima, Yuki, Hiroshi Yoshida, Rui Kitadai, et al.. (2022). High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer. Journal of Gynecologic Oncology. 33(6). e82–e82. 8 indexed citations

Saito, Ayumi, Tadaaki Nishikawa, Hiroshi Yoshida, et al.. (2022). Folate receptor alpha expression is widely observed in uterine and ovarian carcinosarcoma (209). Gynecologic Oncology. 166. S116–S117.

Yazaki, Shu, Roberto Salgado, Tatsunori Shimoi, et al.. (2022). Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British Journal of Cancer. 128(4). 568–575. 9 indexed citations

10.

Saito, Ayumi, Maki Tanioka, Makoto Hirata, et al.. (2022). Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variant. Cancer Treatment and Research Communications. 32. 100587–100587.

11.

Shimomura, Akihiko, Masayuki Yoshida, Takashi Kubo, et al.. (2022). Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer. Breast Cancer Research and Treatment. 197(3). 593–602.

12.

Takeyasu, Yuki, Hitomi Sumiyoshi Okuma, Yuki Kojima, et al.. (2021). Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors. JCO Precision Oncology. 5(5). 756–766. 22 indexed citations

13.

Yonemori, Kan, et al.. (2020). Safety and Evidence of Off-Label Use of Approved Drugs at the National Cancer Center Hospital in Japan. JCO Oncology Practice. 17(3). e416–e425. 11 indexed citations

14.

Shimomura, Akihiko, Asuka Kawachi, Hitomi Sumiyoshi Okuma, et al.. (2019). Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population. Breast Cancer. 26(4). 492–498. 13 indexed citations

15.

Shimoi, Tatsunori, Hitomi Sumiyoshi Okuma, Asuka Kawachi, et al.. (2019). Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Medical Oncology. 36(7). 58–58. 7 indexed citations

16.

Shimomura, Akihiko, Tatsunori Shimoi, Kazuki Sudo, et al.. (2018). Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study. Cancer Chemotherapy and Pharmacology. 82(2). 275–283. 2 indexed citations

17.

Noguchi, Emi, Kenji Tamura, Masaya Hattori, et al.. (2018). Trastuzumab emtansine plus pertuzumab in Japanese patients with HER2-positive metastatic breast cancer: a phase Ib study. Breast Cancer. 26(1). 39–46. 1 indexed citations

18.

Shimoi, Tatsunori, Akihiko Shimomura, Emi Noguchi, et al.. (2017). Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study. BMC Cancer. 17(1). 819–819. 12 indexed citations

19.

Yunokawa, Mayu, Hiroshi Yoshida, Reiko Watanabe, et al.. (2017). Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer. Cancer Chemotherapy and Pharmacology. 80(1). 127–134. 16 indexed citations

20.

Noguchi, Emi, et al.. (2006). Intercalation of (3-Aminopropyl) triethoxysilane and (3-Aminopropyl) diethoxymethylsilane into Montmorillonite(Characterization of Clays,Proceedings of the 13^ International Clay Conference). Clay science. 12(2). 71–75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact